This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …

The recommendations provided in this document provide a data-supported approach to the
diagnosis, staging and treatment of patients diagnosed with hepatocellular carcinoma …

This document presents official recommendations of the American Association for the Study
of Liver Diseases (AASLD) on the surveillance, diagnosis, and treatment of hepatocellular …

These recommendations provide a data-supported approach to the diagnosis, staging and
treatment of patients diagnosed with hepatocellular carcinoma (HCC). They are based on …

This guidance provides a data-supported approach to the diagnosis, staging, and treatment
of patients diagnosed with hepatocellular carcinoma (HCC). A guidance document is …

Since the publication of the American Association for the Study of Liver Diseases (AASLD)
practice guidelines on the management of hepatocellular carcinoma (HCC) in 2005, new …

EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …

EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …

Hepatocellular carcinoma (HCC) is one of the major causes of morbidity, mortality, and
healthcare expenditure in patients with chronic liver disease in India. The Indian National …

Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …